SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-322291
Filing Date
2020-12-21
Accepted
2020-12-21 07:15:29
Documents
3
Period of Report
2020-12-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d47487d8k.htm 8-K 17449
2 EX-99.1 d47487dex991.htm EX-99.1 11815
3 GRAPHIC g47487g05m35.jpg GRAPHIC 9499
  Complete submission text file 0001193125-20-322291.txt   43559
Mailing Address 2280 INWOOD ROAD DALLAS TX 75235
Business Address 2280 INWOOD ROAD DALLAS TX 75235 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 201402372
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences